Marie-Paule Fernandez-Gerlinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marie-Paule Fernandez-Gerlinger has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
A. Meffre
Service de médecine interne, Hôpital Ambroise Paré, AP-HP, 92104 Boulogne-Billancourt, France
1 shared publication- Anne-Sophie Jannot
Biomedical Informatics and Public Health Department UPL Univ Paris Nanterre F92000 Nanterre France
1 shared publication - Benjamin Bouyer
IHU LIRYC (Institut Hospitalo Universitaire - L'institut de Rythmologie et de Modélisation Cardiaque), CRTCB (Centre de Recherche Cardiothoracique de Bordeaux), INSERM 1045, University of Bordeaux, France (H.C., N.D., B.B., R.T., T.P., X.P.B., M.H., J.D., B.S., F.R., N.T., Z.J., J.-B.T., X.I., P.J., F.S.).
1 shared publication David Lebeaux
Unité Mobile de Microbiologie Clinique, Service de Microbiologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France
1 shared publication- Elisabeth Rouveix
Service de médecine interne, Hôpital Ambroise Paré, AP-HP, 92104 Boulogne-Billancourt, France; Université Versailles-Saint-Quentin-en-Yvelines, 78000 Versailles, France
1 shared publication - Erik Bernard
Département de Médecine Générale PIFO, Université Versailles Saint-Quentin en Yvelines, 78280 Guyancourt, France
1 shared publication
Latest Publications
- 20 September 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 68 (11) , 1856-1861
Successful 6-Week Antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery
The incidence of spinal surgical site infections (SSI) remains stable at less than 10%. Surgical reinterventions may be hampered by decubitus, treatment-related adverse events, and cost. In the context of emergence of bacterial resistance, a short duration of antimicrobial treatment is of critical importance. If the duration of treatment for SSI is currently 12 weeks, the aim of our study was to assess the efficacy of an antimicrobial treatment shortened to six weeks. This prospective study was carried out from November 2014 to July 2016 in an 827-bed teaching hospital. After surgical management of SSI, patients received broad-spectrum antibiotics, intravenously for 10 days and orally for the remainder, for a total of six weeks. Success was defined as absence of relapse, superinfection or surgical failure at the end of treatment and at one-year follow-up. Eighty-five patients were included in this study. The median delay between initial surgery and diagnosis of SSI was 16 days. In 65 cases (76·4 %) SSIs were monomicrobial and among these, Staphylococcus aureus was found in 30 cases (46 %). Failure was observed in 7 cases (8·2%), with over half of them caused by anaerobic bacteria. Surgical management of SSI followed by a 6-week antibiotic treatment is associated with favourable outcome. Anaerobic bacteria seem to play a role in the occurrence of relapses. A 6-week reduction in antibiotic treatment leads to reduction in cost and, likely, also to reduction in the emergence and spread of resistant microorganisms.
- 20 September 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 68 (11) , 1856-1861
Successful 6-Week Antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery
The incidence of spinal surgical site infections (SSI) remains stable at less than 10%. Surgical reinterventions may be hampered by decubitus, treatment-related adverse events, and cost. In the context of emergence of bacterial resistance, a short duration of antimicrobial treatment is of critical importance. If the duration of treatment for SSI is currently 12 weeks, the aim of our study was to assess the efficacy of an antimicrobial treatment shortened to six weeks. This prospective study was carried out from November 2014 to July 2016 in an 827-bed teaching hospital. After surgical management of SSI, patients received broad-spectrum antibiotics, intravenously for 10 days and orally for the remainder, for a total of six weeks. Success was defined as absence of relapse, superinfection or surgical failure at the end of treatment and at one-year follow-up. Eighty-five patients were included in this study. The median delay between initial surgery and diagnosis of SSI was 16 days. In 65 cases (76·4 %) SSIs were monomicrobial and among these, Staphylococcus aureus was found in 30 cases (46 %). Failure was observed in 7 cases (8·2%), with over half of them caused by anaerobic bacteria. Surgical management of SSI followed by a 6-week antibiotic treatment is associated with favourable outcome. Anaerobic bacteria seem to play a role in the occurrence of relapses. A 6-week reduction in antibiotic treatment leads to reduction in cost and, likely, also to reduction in the emergence and spread of resistant microorganisms.
- 8 April 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (7) , 845-851
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic Patients
OBJECTIVE: Invasive aspergillosis (IA) is a rare but severe infection caused by Aspergillus spp. that often develops in immunocompromised patients. Lethality remains high in this population. Therefore, preventive strategies are of key importance. The impact of a mobile air decontamination system (Plasmair, AirInSpace, Montigny-le-Bretonneux, France) on the incidence of IA in neutropenic patients was evaluated in this study.DESIGN: Retrospective cohort studyMETHODS: Patients with chemotherapy-induced neutropenia lasting 7 days or more were included over a 2-year period. Cases of IA were confirmed using the revised European Organization for Research and Treatment of Cancer (EORTC) criteria. We took advantage of a partial installation of Plasmair systems in the hematology intensive care unit during this period to compare patients treated in Plasmair-equipped versus non-equipped rooms. Patients were assigned to Plasmair-equipped or non-equipped rooms depending only on bed availability. Differences in IA incidence in both groups were compared using Fisher’s exact test, and a multivariate analysis was performed to take into account potential confounding factors.RESULTS: Data from 156 evaluable patients were available. Both groups were homogenous in terms of age, gender, hematological diagnosis, duration of neutropenia, and prophylaxis. A total of 11 cases of probable IA were diagnosed: 10 in patients in non-equipped rooms and only 1 patient in a Plasmair-equipped room. The odds of developing IA were much lower for patients hospitalized in Plasmair-equipped rooms than for patients in non-equipped rooms (P=.02; odds ratio [OR] =0.11; 95% confidence interval [CI], 0.00–0.84).CONCLUSION: In this study, Plasmair demonstrated a major impact in reducing the incidence of IA in neutropenic patients with hematologic malignancies.Infect Control Hosp Epidemiol 2016;37:845–851
- 8 April 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (7) , 845-851
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic Patients
OBJECTIVE: Invasive aspergillosis (IA) is a rare but severe infection caused by Aspergillus spp. that often develops in immunocompromised patients. Lethality remains high in this population. Therefore, preventive strategies are of key importance. The impact of a mobile air decontamination system (Plasmair, AirInSpace, Montigny-le-Bretonneux, France) on the incidence of IA in neutropenic patients was evaluated in this study.DESIGN: Retrospective cohort studyMETHODS: Patients with chemotherapy-induced neutropenia lasting 7 days or more were included over a 2-year period. Cases of IA were confirmed using the revised European Organization for Research and Treatment of Cancer (EORTC) criteria. We took advantage of a partial installation of Plasmair systems in the hematology intensive care unit during this period to compare patients treated in Plasmair-equipped versus non-equipped rooms. Patients were assigned to Plasmair-equipped or non-equipped rooms depending only on bed availability. Differences in IA incidence in both groups were compared using Fisher’s exact test, and a multivariate analysis was performed to take into account potential confounding factors.RESULTS: Data from 156 evaluable patients were available. Both groups were homogenous in terms of age, gender, hematological diagnosis, duration of neutropenia, and prophylaxis. A total of 11 cases of probable IA were diagnosed: 10 in patients in non-equipped rooms and only 1 patient in a Plasmair-equipped room. The odds of developing IA were much lower for patients hospitalized in Plasmair-equipped rooms than for patients in non-equipped rooms (P=.02; odds ratio [OR] =0.11; 95% confidence interval [CI], 0.00–0.84).CONCLUSION: In this study, Plasmair demonstrated a major impact in reducing the incidence of IA in neutropenic patients with hematologic malignancies.Infect Control Hosp Epidemiol 2016;37:845–851
- 1 August 2015
- Published by Elsevier in Journal of Clinical Virology
- Vol. 69, 40-43
HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?
- 1 August 2015
- Published by Elsevier in Journal of Clinical Virology
- Vol. 69, 40-43
HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?
- Open Access
- 30 May 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 526
What do patients think about HIV mass screening in France? A qualitative study
Background: Since 2009, HIV mass screening of the 15–70-year-old general population in low-risk situations has been recommended in France. This, not yet implemented, untargeted screening would be cost-effective with a positive impact on public health. No previous studies had interrogated primary care patients about it. This study aimed at exploring perceptions of patients attending general practitioner’s on HIV mass screening and at identifying barriers to its implementation. Methods: We conducted a qualitative study through semi-structured individual interviews. Participants were recruited according to age, gender and location of their physician’s practice. Data analysis was based on triangulation by two researchers. Results: Twenty-four interviews were necessary to obtain data saturation. HIV transmission was mostly associated with sexual intercourse; main barriers stemming from the screening were related to sexuality, often seen as questioning spouse’s faithfulness. It could interfere with religiosity, implying an upsetting perception of sexuality among the elderly. Patients’ beliefs and perceptions regarding HIV/AIDS, the fear to be screened and difficulties to talk about sexuality were other barriers. Conclusion: To our knowledge, no studies had previously interrogated primary care patients about barriers to HIV mass screening in France. Although relevance of this untargeted screening is debated in France, our results could be helpful to a better understanding of patients’ attitudes toward this and to an outstanding contribution to reduce the number of new cases of HIV contamination.
- 30 May 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 526
Open AccessWhat do patients think about HIV mass screening in France? A qualitative study
Background: Since 2009, HIV mass screening of the 15–70-year-old general population in low-risk situations has been recommended in France. This, not yet implemented, untargeted screening would be cost-effective with a positive impact on public health. No previous studies had interrogated primary care patients about it. This study aimed at exploring perceptions of patients attending general practitioner’s on HIV mass screening and at identifying barriers to its implementation. Methods: We conducted a qualitative study through semi-structured individual interviews. Participants were recruited according to age, gender and location of their physician’s practice. Data analysis was based on triangulation by two researchers. Results: Twenty-four interviews were necessary to obtain data saturation. HIV transmission was mostly associated with sexual intercourse; main barriers stemming from the screening were related to sexuality, often seen as questioning spouse’s faithfulness. It could interfere with religiosity, implying an upsetting perception of sexuality among the elderly. Patients’ beliefs and perceptions regarding HIV/AIDS, the fear to be screened and difficulties to talk about sexuality were other barriers. Conclusion: To our knowledge, no studies had previously interrogated primary care patients about barriers to HIV mass screening in France. Although relevance of this untargeted screening is debated in France, our results could be helpful to a better understanding of patients’ attitudes toward this and to an outstanding contribution to reduce the number of new cases of HIV contamination.